EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Before thalidomide: Heinrich Mückter and the Nazi typhus complex

Lukas Frank, Dominik Groß, Nico Biermanns iD

Medical History · 2026-07 · 70 (3) · 449-475

DOI: 10.1017/mdh.2026.10059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical History, online erschienen am 20.04.2026. Verfasst von Lukas Frank und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for History, Theory and Ethics of Medicine, https://ror.org/04xfq0f34Medical Faculty, RWTH Aachen University, Aachen, Germany. Die Arbeit nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The physician and chemist Heinrich Mückter (1914–87) is widely known for his role in developing thalidomide at Grünenthal, whose market launch led to one of the most serious pharmaceutical scandals in history. Less scholarly attention has been paid, however, to his involvement in Nazi Germany’s typhus control and vaccine research and production between 1942 and 1945. Drawing on a variety of historical sources, this article reconstructs his work at a delousing facility in the Białystok District and at the Institute for Typhus and Virus Research of the German Army High Command in Krakow under hygienist Hermann Eyer (1906–97). We show that Mückter participated in a racially framed typhus control programme and in ethically dubious vaccine production methods. He also conducted unethical and methodologically questionable vaccine experiments on human beings in Krakow, including underage test subjects and exploiting the structural vulnerability of the occupied Polish population. In addition, we reassess assumptions about cooperation between Eyer’s Wehrmacht institute and the research station at Buchenwald concentration camp under SS physician Erwin Ding-Schuler (1912–45). Taken together, we argue that Mückter operated within a broader network of civilian and military scientists, health officials, and representatives of the pharmaceutical industry who accelerated the erosion of ethical boundaries in biomedical research and contributed to an exterminatory health and population policy in the occupied East. These practices, termed the ‘Nazi typhus complex’, reveal how preventive medicine, biomedical research, and exterminatory policies were intertwined in the context of an anti-Slavic war of annihilation and the Holocaust.

Schlagwörter

Stichwörter der Autor:innen

BuchenwaldConterganDelousingHolocaustHuman experimentationVaccine research

Autor:innen und Institutionen

  • Institute for History, Theory and Ethics of Medicine, https://ror.org/04xfq0f34Medical Faculty, RWTH Aachen University, Aachen, Germany.

ORCID-Profile: Nico Biermanns

Zitieren

APA

Frank, L., Groß, D., & Biermanns, N. (2026). Before thalidomide: Heinrich Mückter and the Nazi typhus complex. Medical History, 70(3), 449-475. https://doi.org/10.1017/mdh.2026.10059

Vancouver

Frank L, Groß D, Biermanns N. Before thalidomide: Heinrich Mückter and the Nazi typhus complex. Medical History. 2026;70(3):449-475. doi:10.1017/mdh.2026.10059

BibTeX
@article{Frank2026,
  author = {Frank, Lukas and Groß, Dominik and Biermanns, Nico},
  title = {Before thalidomide: Heinrich Mückter and the Nazi typhus complex},
  journal = {Medical History},
  year = {2026},
  volume = {70},
  number = {3},
  pages = {449--475},
  doi = {10.1017/mdh.2026.10059}
}
Kostenlos starten →